Kidney cancer surgery heart risk study pulled before starting
NCT ID NCT06515431
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study was designed to find out how often people develop hidden heart damage after kidney removal for cancer. Researchers planned to measure a blood marker of heart injury in 120 patients. However, the study was withdrawn before enrolling anyone, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Started
-
Apr 2024
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Surgery waiting lists will be screened by members of the research team at Sheffield Teaching Hospitals to identify patients that will be undergoing a radical nephrectomy for suspected renal cancer. The surgical approach will already have been decided before the study is introduced. Those eligible will be contacted via phone to discuss the study further.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria * Adult patients (aged 18 and above) * Undergoing a radical nephrectomy (either laparoscopic or robotic) for suspected renal cancer * Stage \<T3a * Can provide informed consent Exclusion Criteria * Patients under 18 * Undergoing partial nephrectomy * Undergoing radical nephrectomy not for suspected renal cancer * Unable to provide informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Myocardial injury are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield, S10 2JF, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- After a stroke, does the heart inflame? MRI study probes the link
- Can a peptide drug shield the hearts of ICU patients?
- Can two drugs shrink kidney tumors and their vein clots before surgery?
- Blood test aims to catch Cancer's return earlier
- Can a new drug target Hard-to-Treat kidney and ovarian cancers?
- Personalized dosing could tame kidney cancer Drug's side effects